Andrea Antinori to Betacoronavirus
This is a "connection" page, showing publications Andrea Antinori has written about Betacoronavirus.
Connection Strength
0.057
-
Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Cell Death Dis. 2020 10 27; 11(10):921.
Score: 0.010
-
"Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial". Trials. 2020 Oct 22; 21(1):875.
Score: 0.010
-
Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay. Viruses. 2020 10 20; 12(10).
Score: 0.010
-
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis. 2020 10 30; 30(11):1899-1913.
Score: 0.009
-
Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19). Cell Death Differ. 2020 11; 27(11):3196-3207.
Score: 0.009
-
Reply to the Letter "COVID-19-Associated Encephalopathy and Cytokine-Mediated Neuroinflammation". Ann Neurol. 2020 10; 88(4):861-862.
Score: 0.005
-
Steroid-Responsive Encephalitis in Coronavirus Disease 2019. Ann Neurol. 2020 08; 88(2):423-427.
Score: 0.002
-
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy. Neurology. 2020 08 18; 95(7):e910-e920.
Score: 0.002